P3.12 Small molecule compounds that correct alternative splicing of the SMN2 gene and restore SMN protein expression and function

2011 ◽  
Vol 21 (9-10) ◽  
pp. 685
Author(s):  
N.A. Naryshkin ◽  
J. Narasimhan ◽  
A. Dakka ◽  
V. Gabbeta ◽  
M. Haley ◽  
...  
2012 ◽  
Vol 22 (9-10) ◽  
pp. 848 ◽  
Author(s):  
N. Naryshkin ◽  
J. Narasimhan ◽  
A. Dakka ◽  
V. Gabbeta ◽  
M. Haley ◽  
...  

2014 ◽  
Vol 19 (7) ◽  
pp. 1000-1013 ◽  
Author(s):  
John W. Cuozzo ◽  
Holly H. Soutter

Production of novel soluble and membrane-localized protein targets for functional and affinity-based screening has often been limited by the inability of traditional protein-expression systems to generate recombinant proteins that have properties similar to those of their endogenous counterparts. Such targets have often been labeled as challenging. Although biological validation of these challenging targets for specific disease areas may be strong, discovery of small-molecule modulators can be greatly delayed or completely halted due to target-expression issues. In this article, the limitations of traditional protein-expression systems will be discussed along with new systems designed to overcome these challenges. Recent work in this field has focused on two major areas for both soluble and membrane targets: construct-design strategies to improve expression levels and new hosts that can carry out the posttranslational modifications necessary for proper target folding and function. Another area of active research has been on the reconstitution of solubilized membrane targets for both structural analysis and screening. Finally, the potential impact of these new systems on the output of small-molecule screening campaigns will be discussed.


2015 ◽  
Vol 86 ◽  
pp. 138-146 ◽  
Author(s):  
Peili Li ◽  
Yasutaka Kurata ◽  
Nani Maharani ◽  
Endang Mahati ◽  
Katsumi Higaki ◽  
...  

2016 ◽  
Vol 14 (1) ◽  
pp. nrs.14002 ◽  
Author(s):  
Shailaja D. Divekar ◽  
Deanna M. Tiek ◽  
Aileen Fernandez ◽  
Rebecca B. Riggins

Estrogen-related receptors (ERRs) are founding members of the orphan nuclear receptor (ONR) subgroup of the nuclear receptor superfamily. Twenty-seven years of study have yet to identify cognate ligands for the ERRs, though they have firmly placed ERRα (ESRRA) and ERRγ (ESRRG) at the intersection of cellular metabolism and oncogenesis. The pace of discovery for novel functions of ERRβ (ESRRB), however, has until recently been somewhat slower than that of its family members. ERRβ has also been largely ignored in summaries and perspectives of the ONR literature. Here, we provide an overview of established and emerging knowledge of ERRβ in mouse, man, and other species, highlighting unique aspects of ERRβ biology that set it apart from the other two estrogen-related receptors, with a focus on the impact of alternative splicing on the structure and function of this receptor.


2007 ◽  
Vol 57 (1) ◽  
pp. 67-80 ◽  
Author(s):  
Melissa J. Costello ◽  
Shawna K. Joyce ◽  
Vikki M. Abrahams

2002 ◽  
Vol 363 (3) ◽  
pp. 449-455 ◽  
Author(s):  
Dimitri TCHERNITCHKO ◽  
Monique BOURGEOIS ◽  
Marie-Elise MARTIN ◽  
Carole BEAUMONT

Nramp2/DMT1 is a transmembrane proton-coupled Fe2+ transporter. Two different mRNAs are generated by alternative splicing; isoform I contains an iron responsive element (IRE), whereas isoform II does not. They encode two proteins differing at their C-terminal end and by their subcellular localization. IRE-mediated stabilization of isoform I mRNA is thought to stimulate DMT1 expression in response to iron deficiency. We have measured the two mRNAs by real-time quantitative PCR in several mouse tissues, in normal conditions or following injection of phenylhydrazine, a potent haemolytic agent. Isoform I mRNA is expressed in the duodenum and is induced by stimulation of erythropoiesis, whereas the non-IRE isoform is mostly induced in erythropoietic spleen. Surprisingly, both isoforms are highly expressed in the kidney and are not regulated by erythropoiesis. To evaluate the role of the IRE in regulating isoform I mRNA stability, in response to variations in cell iron status, several constructs were made in pCDNA3 with either a normal or a mutated IRE placed at the 3′ end of a stable mRNA. These constructs were transfected into HT29 cells and mRNAs were analysed after growing cells in the presence or absence of exogenous iron. There was no difference in the level of expression of the different messages, suggesting that the IRE does not regulate stability of isoform I mRNA. The half-life of the endogenous IRE-mRNA was also measured following actinomycin D addition in iron- or desferrioxamine-treated cells. Decay of the mRNA was very similar in both conditions. These results suggest that additional transcriptional regulations at the promoter level, or iron-dependent regulation of alternative splicing are likely to participate in the induction of isoform I mRNA by iron deficiency.


Sign in / Sign up

Export Citation Format

Share Document